5-arylindole derivatives

Details 5-arylindole derivatives 5-arylindole derivatives

1998-11-13

1999-11-30

Shah, Mukund J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514241, 514245, 544182, 544212, 544217, 544218, 544219, C07D25306, C07D25112, A61K 3153, A61K 3140

Patent

active

059943521

ABSTRACT:
Compounds of the formula ##STR1## wherein A, B, D, E, and F are each independently nitrogen or carbon; R.sub.1 is hydrogen, C.sub.1 to C.sub.6 alkyl, --(CH.sub.2).sub.n R.sub.7, or C.sub.1 to C.sub.3 alkyl-aryl; R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are each independently hydrogen, C.sub.1 to C.sub.6 alkyl, aryl, C.sub.1 to C.sub.3 alkyl-aryl, halogen, cyano, nitro, --(CH.sub.2).sub.m NR.sub.8 R.sub.9, --(CH.sub.2).sub.m OR.sub.9, --SR.sub.9, --SO.sub.2 NR.sub.8 R.sub.9, --(CH.sub.2).sub.m NR.sub.8 SO.sub.2 R.sub.9, --(CH.sub.2).sub.m NR.sub.8 CO.sub.2 R.sub.9, --(CH.sub.2).sub.m NR.sub.8 COR.sub.9, --(CH.sub.2).sub.m CONR.sub.7 R.sub.9, or --(CH.sub.2).sub.m CO.sub.2 R.sub.9 ; R.sub.2 and R.sub.3, R.sub.3 and R.sub.4, R.sub.4 and R.sub.5, and R.sub.5 and R.sub.6 may be taken together to form a five- to seven-membered alkyl ring, a six-membered ary ring, a five- to seven-membered heteroalkyl ring, having 1 heteroatom of N, O, or S, or a five- to six-membered heteroaryl ring having 1 or 2 heteroatoms of N, O, or S; R.sub.7 is --OR.sub.10, --SR0.sub.10, --SO.sub.2 NR.sub.10 R.sub.11, --NR.sub.10 SO.sub.2 R.sub.11, --NR.sub.10 CO.sub.2 R.sub.11, --NR.sub.10 COR.sub.11, --CONR.sub.10 R.sub.11, or --CO.sub.2 R.sub.10 ; R.sub.8, R.sub.9, R.sub.10 and R.sub.11 are each independently hydrogen, C.sub.1 to C.sub.6 alkyl, or C.sub.1 to C.sub.3 alkyl-aryl; m is 0, 1, or 2; n is 2, 3, or 4; and the above aryl groups and the aryl moieties of the above alkyl-aryl groups are each independently phenyl or substituted phenyl, wherein said substituted phenyl may be substituted with one to three of C.sub.1 to C.sub.4 alkyl, halogen, hydroxy, cyano, carboxamido, nitro, or C.sub.1 to C.sub.4 alkoxy, and the pharmaceutically acceptable salts thereof. These compounds are useful in treating migraine and other disorders and are new. These compounds are useful psychotherapeutics and are potent serotonin (5-HT.sub.1) agonists and may be used in the treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain, and chronic paroxysmal hemicrania and headache associated with vascular disorders, and other disorders arising from deficient serotonergic neurotransmission. The compounds can also be used as centrally acting antihypertensives and vasodilators.

REFERENCES:
patent: 2773875 (1956-12-01), Finkelstein
patent: 3037031 (1962-05-01), Lewis et al.
patent: 4252803 (1981-02-01), Webb
patent: 4803218 (1989-02-01), Stanley et al.
patent: 4855314 (1989-08-01), Oxford et al.
patent: 5208248 (1993-05-01), Baker et al.
patent: 5348968 (1994-09-01), Lavielle
patent: 5409941 (1995-04-01), Nowakowski
patent: 5498626 (1996-03-01), Macor
patent: 5502065 (1996-03-01), Brown et al.
patent: 5545644 (1996-08-01), Macor et al.
patent: 5559129 (1996-09-01), Macor et al.
patent: 5578612 (1996-11-01), Macor et al.
patent: 5594014 (1997-01-01), Macor et al.
patent: 5607951 (1997-03-01), Macor et al.
patent: 5607960 (1997-03-01), Wythes
patent: 5639752 (1997-06-01), Macor
patent: 5639779 (1997-06-01), Wythes et al.
patent: 5717102 (1998-02-01), Macor et al.
patent: 5747501 (1998-05-01), Macor et al.
Bader, et al.., J. Am Chem. Soc. 79, 5686-5689 (1957).
A.P. Gray, J. Org, Chem., 23, 1453-1454 (1958).
Moore, et al., J. Org. Chem., 20. 2860-2864 (1964).
Cain, et al., J. Am Chem. Soc., 105 908,911, 912 (1983).
Markowitz, et al. J. Neurosci, 7 (12) 4736 (1987).
Lee, et al., Brain Res., 626, 303-305 (1993).
P.P.A. Humphrey, et al., Br. J. Pharmacol, 94, 1128 (1988).
W. Fernik, et al., Br. J. Pharmacol, 96, 83 (1989).
Reggent for Org. Syn 1, 112 (1967).
Mohr, et al., Tetrahedron, 38(1), 147-152 (1982).
Friderichs, et al., Chem. Ab., 83, 28056 (1975).
Kiyooke, et al., J. Org. Chem, 5409 (1989).
Hamada, et al., Chem. Pharm. Bull., 1921 (1982).
Lee, et al., Soc. Neurosci [Nov. 1993] Meeting 19 (Part 2), #565.6.
Moskowitz, 7th World Congress on Pain Aug. 1993, #667.
Leonard, et al., Neuropharm, 11, 373-384 (1972).

Affiliated with

Also associated with

Rating

5-arylindole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-arylindole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-arylindole derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1672904